Johnson Matthey PLC (LON:JMAT – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is GBX 2,283.33.
A number of research firms have commented on JMAT. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 2,400 price target on shares of Johnson Matthey in a research note on Monday, July 6th. UBS Group reaffirmed a “neutral” rating and issued a GBX 2,200 price objective on shares of Johnson Matthey in a research note on Friday, May 22nd. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 2,330 price objective on shares of Johnson Matthey in a report on Tuesday, August 4th. Finally, Berenberg Bank raised their target price on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a report on Monday, June 1st.
Get Our Latest Research Report on JMAT
Johnson Matthey Price Performance
Johnson Matthey (LON:JMAT – Get Free Report) last released its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. The business had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%. As a group, research analysts anticipate that Johnson Matthey will post 173.4112903 earnings per share for the current year.
Insider Buying and Selling at Johnson Matthey
In related news, insider Richard Pike acquired 14 shares of Johnson Matthey stock in a transaction dated Wednesday, June 10th. The shares were acquired at an average cost of GBX 1,990 per share, for a total transaction of £278.60. Also, insider Alastair Judge bought 12 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The stock was bought at an average price of GBX 2,193 per share, with a total value of £263.16. Insiders bought 6,974 shares of company stock valued at $15,102,970 in the last 90 days. Corporate insiders own 0.58% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
